At RxRevu we believe in improving the value of healthcare through informed, consistent prescription decisions. We also believe that lasting changes require a dedicated intention and aligned effort, and we are committed to investing in the future of healthcare. We leverage Prescription Decision Support (PDS) to deliver real-time, patient-specific cost information, electronic prior authorization, and therapeutic alternatives at the point of care. By doing so, we enable shared decisions between providers and patients, help patients get the right medication the first time, and remove friction from the point of care to fulfillment.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

AI

YEXT LAUNCHES AI-POWERED DOCTOR FINDER SOLUTION TO MAKE SEARCHING FOR HEALTHCARE PROVIDERS A SEAMLESS EXPERIENCE

Yext | September 08, 2021

news image

Yext, Inc., the AI Search Company, today announced the availability of "Find-a-Doc," an AI-powered search solution for healthcare organizations to improve the pre-appointment patient experience. Built on Answers, Yext's revolutionary search platform, Find-a-Doc enables patients to quickly and easily identify the right provider for their needs on a healthcare organization's website. When a patient searches for a specific doctor specialty, insurance ...

Read More

Health Technology

ENDEAVOUR VISION HAS CLOSED ENDEAVOUR MEDTECH GROWTH II LP FOR USD 375 MILLION TO INVEST IN TRANSFORMATIVE HEALTHCARE TECHNOLOGY

Endeavour Vision | April 23, 2021

news image

Endeavour Vision today announced the closure of Endeavour Medtech Growth II (EMG II) LP at a total capital commitment of USD 375 million. The fund will follow the same approach as its predecessor, which was to help early-stage Medtech and digital health advances that advance the quality of care and improve healthcare system efficiencies. EMG II LP was funded by both current and returning investors, inclu...

Read More

WALGREENS REPORTS DATA BREACH FROM PERSONAL MOBILE MESSAGING APP ERROR

HealthITSecurity | March 02, 2020

news image

Walgreens announced on Friday that it inadvertently exposed the personal messages stored on its messaging app due to an internal error. On January 15, officials said they first discovered an error in the Walgreens personal secure messaging features and launched an investigation. They found a data compromise, which allowed personal messages stored on its database to be viewable by other customers. Upon discovery, Walgreens temporarily disabled message viewing to prevent continued exposure and &ld...

Read More

BIO PRODUCTS LABORATORY ANNOUNCES LAUNCH OF ALBUMINEX® 5% AND ALBUMINEX® 25% WITH SUPPLY IMMEDIATELY AVAILABLE IN THE UNITED STATES

Bio Products Laboratory | May 29, 2020

news image

Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection, with supply immediately available. ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovole...

Read More
news image

AI

YEXT LAUNCHES AI-POWERED DOCTOR FINDER SOLUTION TO MAKE SEARCHING FOR HEALTHCARE PROVIDERS A SEAMLESS EXPERIENCE

Yext | September 08, 2021

Yext, Inc., the AI Search Company, today announced the availability of "Find-a-Doc," an AI-powered search solution for healthcare organizations to improve the pre-appointment patient experience. Built on Answers, Yext's revolutionary search platform, Find-a-Doc enables patients to quickly and easily identify the right provider for their needs on a healthcare organization's website. When a patient searches for a specific doctor specialty, insurance ...

Read More
news image

Health Technology

ENDEAVOUR VISION HAS CLOSED ENDEAVOUR MEDTECH GROWTH II LP FOR USD 375 MILLION TO INVEST IN TRANSFORMATIVE HEALTHCARE TECHNOLOGY

Endeavour Vision | April 23, 2021

Endeavour Vision today announced the closure of Endeavour Medtech Growth II (EMG II) LP at a total capital commitment of USD 375 million. The fund will follow the same approach as its predecessor, which was to help early-stage Medtech and digital health advances that advance the quality of care and improve healthcare system efficiencies. EMG II LP was funded by both current and returning investors, inclu...

Read More
news image

WALGREENS REPORTS DATA BREACH FROM PERSONAL MOBILE MESSAGING APP ERROR

HealthITSecurity | March 02, 2020

Walgreens announced on Friday that it inadvertently exposed the personal messages stored on its messaging app due to an internal error. On January 15, officials said they first discovered an error in the Walgreens personal secure messaging features and launched an investigation. They found a data compromise, which allowed personal messages stored on its database to be viewable by other customers. Upon discovery, Walgreens temporarily disabled message viewing to prevent continued exposure and &ld...

Read More
news image

BIO PRODUCTS LABORATORY ANNOUNCES LAUNCH OF ALBUMINEX® 5% AND ALBUMINEX® 25% WITH SUPPLY IMMEDIATELY AVAILABLE IN THE UNITED STATES

Bio Products Laboratory | May 29, 2020

Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection, with supply immediately available. ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovole...

Read More